CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
Lancet, Jeffrey E, Uy, Geoffrey L, Cortes, Jorge E, Newell, Laura F, Lin, Tara L, Ritchie, Ellen K, Stuart, Robert K, Strickland, Stephen A, Hogge, Donna, Solomon, Scott R, Stone, Richard M, Bixby, Dale L, Kolitz, Jonathan E, Schiller, Gary J, Wieduwilt, Matthew J, Ryan, Daniel H, Hoering, Antje, Banerjee, Kamalika, Chiarella, Michael, Louie, Arthur C, Medeiros, Bruno C
Published in Journal of clinical oncology (10.09.2018)
Published in Journal of clinical oncology (10.09.2018)
Get full text
Journal Article
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
Shah, Bijal D, Ghobadi, Armin, Oluwole, Olalekan O, Logan, Aaron C, Boissel, Nicolas, Cassaday, Ryan D, Leguay, Thibaut, Bishop, Michael R, Topp, Max S, Tzachanis, Dimitrios, O'Dwyer, Kristen M, Arellano, Martha L, Lin, Yi, Baer, Maria R, Schiller, Gary J, Park, Jae H, Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C, Wierda, William G, DeAngelo, Daniel J, Stiff, Patrick, Jeyakumar, Deepa, Feng, Chaoling, Dong, Jinghui, Shen, Tong, Milletti, Francesca, Rossi, John M, Vezan, Remus, Masouleh, Behzad Kharabi, Houot, Roch
Published in The Lancet (British edition) (07.08.2021)
Published in The Lancet (British edition) (07.08.2021)
Get full text
Journal Article
Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML
Cortes, Jorge E., Tallman, Martin S., Schiller, Gary J., Trone, Denise, Gammon, Guy, Goldberg, Stuart L., Perl, Alexander E., Marie, Jean-Pierre, Martinelli, Giovanni, Kantarjian, Hagop M., Levis, Mark J.
Published in Blood (09.08.2018)
Published in Blood (09.08.2018)
Get full text
Journal Article
Venetoclax Plus Gilteritinib for FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia
Daver, Naval, Perl, Alexander E, Maly, Joseph, Levis, Mark, Ritchie, Ellen, Litzow, Mark, McCloskey, James, Smith, Catherine C, Schiller, Gary, Bradley, Terrence, Tiu, Ramon V, Naqvi, Kiran, Dail, Monique, Brackman, Deanna, Siddani, Satya, Wang, Jing, Chyla, Brenda, Lee, Paul, Altman, Jessica K
Published in Journal of clinical oncology (10.12.2022)
Published in Journal of clinical oncology (10.12.2022)
Get full text
Journal Article
Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial
Perl, Alexander E., Larson, Richard A., Podoltsev, Nikolai A., Strickland, Stephen, Wang, Eunice S., Atallah, Ehab, Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Récher, Christian, Yoon, Sung-Soo, Hosono, Naoko, Onozawa, Masahiro, Chiba, Shigeru, Kim, Hee-Je, Hasabou, Nahla, Lu, Qiaoyang, Tiu, Ramon, Levis, Mark J.
Published in Blood (09.06.2022)
Published in Blood (09.06.2022)
Get full text
Journal Article
Fosmanogepix Therapy of Disseminated Fusarium Infection
Winston, Drew J, Young, Patricia A, Schlamm, Haran T, Schiller, Gary J
Published in Clinical infectious diseases (18.09.2023)
Published in Clinical infectious diseases (18.09.2023)
Get full text
Journal Article
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Thompson, Alexis A, Walters, Mark C, Kwiatkowski, Janet, Rasko, John E.J, Ribeil, Jean-Antoine, Hongeng, Suradej, Magrin, Elisa, Schiller, Gary J, Payen, Emmanuel, Semeraro, Michaela, Moshous, Despina, Lefrere, Francois, Puy, Hervé, Bourget, Philippe, Magnani, Alessandra, Caccavelli, Laure, Diana, Jean-Sébastien, Suarez, Felipe, Monpoux, Fabrice, Brousse, Valentine, Poirot, Catherine, Brouzes, Chantal, Meritet, Jean-François, Pondarré, Corinne, Beuzard, Yves, Chrétien, Stany, Lefebvre, Thibaud, Teachey, David T, Anurathapan, Usanarat, Ho, P. Joy, von Kalle, Christof, Kletzel, Morris, Vichinsky, Elliott, Soni, Sandeep, Veres, Gabor, Negre, Olivier, Ross, Robert W, Davidson, David, Petrusich, Alexandria, Sandler, Laura, Asmal, Mohammed, Hermine, Olivier, De Montalembert, Mariane, Hacein-Bey-Abina, Salima, Blanche, Stéphane, Leboulch, Philippe, Cavazzana, Marina
Published in The New England journal of medicine (19.04.2018)
Published in The New England journal of medicine (19.04.2018)
Get full text
Journal Article
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study
Horwitz, Mitchell E., Stiff, Patrick J., Cutler, Corey, Brunstein, Claudio, Hanna, Rabi, Maziarz, Richard T., Rezvani, Andrew R., Karris, Nicole A., McGuirk, Joseph, Valcarcel, David, Schiller, Gary J., Lindemans, Caroline A., Hwang, William Y.K., Koh, Liang Piu, Keating, Amy, Khaled, Yasser, Hamerschlak, Nelson, Frankfurt, Olga, Peled, Tony, Segalovich, Irit, Blackwell, Beth, Wease, Stephen, Freedman, Laurence S., Galamidi-Cohen, Einat, Sanz, Guillermo
Published in Blood (21.10.2021)
Published in Blood (21.10.2021)
Get full text
Journal Article
Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host
Winston, Drew J, Young, Patricia A, Schlamm, Haran T, Schiller, Gary J
Published in Clinical infectious diseases (16.08.2024)
Published in Clinical infectious diseases (16.08.2024)
Get more information
Journal Article
Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
FISCHER, Thomas, STONE, Richard M, KLIMEK, Virginia M, NIMER, Stephen D, GILLILAND, D. Gary, DUTREIX, Catherine, HUNTSMAN-LABED, Alice, VIRKUS, Jodi, GILES, Francis J, DEANGELO, Daniel J, GALINSKY, Ilene, ESTEY, Elihu, LANZA, Carlo, FOX, Edward, EHNINGER, Gerhard, FELDMAN, Eric J, SCHILLER, Gary J
Published in Journal of clinical oncology (01.10.2010)
Published in Journal of clinical oncology (01.10.2010)
Get full text
Journal Article
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Zeidan, Amer M, Ridinger, Maya, Lin, Tara L, Becker, Pamela S, Schiller, Gary J, Patel, Prapti A, Spira, Alexander I, Tsai, Michaela L, Samuëlsz, Errin, Silberman, Sandra L, Erlander, Mark, Wang, Eunice S
Published in Clinical cancer research (01.12.2020)
Published in Clinical cancer research (01.12.2020)
Get full text
Journal Article
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
Shah, Bijal D., Bishop, Michael R., Oluwole, Olalekan O., Logan, Aaron C., Baer, Maria R., Donnellan, William B., O'Dwyer, Kristen M., Holmes, Houston, Arellano, Martha L., Ghobadi, Armin, Pagel, John M., Lin, Yi, Cassaday, Ryan D., Park, Jae H., Abedi, Mehrdad, Castro, Januario E., DeAngelo, Daniel J., Malone, Adriana K., Mawad, Raya, Schiller, Gary J., Rossi, John M., Bot, Adrian, Shen, Tong, Goyal, Lovely, Jain, Rajul K., Vezan, Remus, Wierda, William G.
Published in Blood (08.07.2021)
Published in Blood (08.07.2021)
Get full text
Journal Article
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
Ravandi, Farhad, Prof, Ritchie, Ellen K, MD, Sayar, Hamid, MD, Lancet, Jeffrey E, MD, Craig, Michael D, MD, Vey, Norbert, Prof, Strickland, Stephen A, MD, Schiller, Gary J, Prof, Jabbour, Elias, MD, Erba, Harry P, Prof, Pigneux, Arnaud, Prof, Horst, Heinz-August, Prof, Recher, Christian, Prof, Klimek, Virginia M, MD, Cortes, Jorge, Prof, Roboz, Gail J, MD, Odenike, Olatoyosi, MD, Thomas, Xavier, MD, Havelange, Violaine, MD, Maertens, Johan, Prof, Derigs, Hans-Günter, Prof, Heuser, Michael, MD, Damon, Lloyd, Prof, Powell, Bayard L, Prof, Gaidano, Gianluca, Prof, Carella, Angelo-Michele, MD, Wei, Andrew, MBBS, Hogge, Donna, Prof, Craig, Adam R, MD, Fox, Judith A, PhD, Ward, Renee, MD, Smith, Jennifer A, PhD, Acton, Gary, MD, Mehta, Cyrus, Prof, Stuart, Robert K, MD, Kantarjian, Hagop M, Prof
Published in The lancet oncology (01.09.2015)
Published in The lancet oncology (01.09.2015)
Get full text
Journal Article
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
Siegel, David S., Schiller, Gary J., Samaras, Christy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Anz, Bertrand, Fonseca, Gustavo, Reece, Donna, Pierceall, William E., Chung, Weiyuan, Zafar, Faiza, Agarwal, Amit, Bahlis, Nizar J.
Published in Leukemia (01.12.2020)
Published in Leukemia (01.12.2020)
Get full text
Journal Article